Oxygenta Pharmaceutical Share Price

Oxygenta Pharmaceutical Limited was initially incorporated as S S Organics Private Limited as a private limited Company in 1990. The Company converted its status to a Public Limited Company in 1993 changing the name to S S Organics Limited. Further, it was changed to Oxygenta Pharmaceutical Limited in FY 202122. The Company was incorporated with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals. It manufactures a wide range of new generation quinolones, antiasthmatic, antiulcerant, and antiinflammatory drugs. The Company has plant located at Medak in Andhra Pradesh. The Company is strong in manufacturing of anti ulcerative and anti bacterial drugs. The Company is doing contract manufacturing work for APL and also having its own production. Apart from these, it is doing contract manufacturing work with APL for manufacturing of Cirprofloxacin HCL from QAcid and has been manufacturing Pantaprozole Sodium and Gabapentine for own production. This contract manufacturing helped the Company to meet major operational expenses. Since the Company started commercial production in July, 2015 after fire accident tragedy, it is in process of stabilizing the manufacturing and marketing.

As of 23 Jan 2026, Oxygenta Pharmaceutical share price is ₹58. The stock opened at ₹57 and had closed at ₹57 the previous day. During today’s trading session, Oxygenta Pharmaceutical share price moved between ₹57.00 and ₹58.50, with an average price for the day of ₹57.75. Over the last 52 weeks, the stock has recorded a low of ₹51.31 and a high of ₹133.50. In terms of performance, Oxygenta Pharmaceutical share price has declined by 47.6% over the past six months and has declined by 29.59% over the last year.